145 related articles for article (PubMed ID: 26812578)
1. Phage Selection of Peptide Macrocycles against β-Catenin To Interfere with Wnt Signaling.
Bertoldo D; Khan MM; Dessen P; Held W; Huelsken J; Heinis C
ChemMedChem; 2016 Apr; 11(8):834-9. PubMed ID: 26812578
[TBL] [Abstract][Full Text] [Related]
2. Bicyclic β-Sheet Mimetics that Target the Transcriptional Coactivator β-Catenin and Inhibit Wnt Signaling.
Wendt M; Bellavita R; Gerber A; Efrém NL; van Ramshorst T; Pearce NM; Davey PRJ; Everard I; Vazquez-Chantada M; Chiarparin E; Grieco P; Hennig S; Grossmann TN
Angew Chem Int Ed Engl; 2021 Jun; 60(25):13937-13944. PubMed ID: 33783110
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
Catrow JL; Zhang Y; Zhang M; Ji H
J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
[TBL] [Abstract][Full Text] [Related]
4. Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators.
Mazur M; Bujak A; Matloka M; Janowska S; Gunerka P; Bojarski L; Stanczak A; Klejman A; Bednarek A; Lamparska-Przybysz M; Wieczorek M
Anal Biochem; 2015 Apr; 475():56-67. PubMed ID: 25659657
[TBL] [Abstract][Full Text] [Related]
5. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
6. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
7. Functional inhibition of β-catenin-mediated Wnt signaling by intracellular VHH antibodies.
Newnham LE; Wright MJ; Holdsworth G; Kostarelos K; Robinson MK; Rabbitts TH; Lawson AD
MAbs; 2015; 7(1):180-91. PubMed ID: 25524068
[TBL] [Abstract][Full Text] [Related]
8. A High-Content Imaging Screen for Cellular Regulators of β-Catenin Protein Abundance.
Zeng X; Montoute M; Bee TW; Lin H; Kallal LA; Liu Y; Agarwal P; Wang D; Lu Q; Morrow D; Pope AJ; Wu Z
J Biomol Screen; 2016 Mar; 21(3):260-8. PubMed ID: 26656867
[TBL] [Abstract][Full Text] [Related]
9. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
10. A Dominant Negative Antisense Approach Targeting β-Catenin.
Vonbrüll M; Riegel E; Halter C; Aigner M; Bock H; Werner B; Lindhorst T; Czerny T
Mol Biotechnol; 2018 May; 60(5):339-349. PubMed ID: 29524201
[TBL] [Abstract][Full Text] [Related]
11. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
Tian W; Han X; Yan M; Xu Y; Duggineni S; Lin N; Luo G; Li YM; Han X; Huang Z; An J
Biochemistry; 2012 Jan; 51(2):724-31. PubMed ID: 22224445
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
[TBL] [Abstract][Full Text] [Related]
13. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
Manigandan K; Manimaran D; Jayaraj RL; Elangovan N; Dhivya V; Kaphle A
Biochimie; 2015 Dec; 119():103-12. PubMed ID: 26482805
[TBL] [Abstract][Full Text] [Related]
14. A zebrafish chemical suppressor screening identifies small molecule inhibitors of the Wnt/β-catenin pathway.
Nishiya N; Oku Y; Kumagai Y; Sato Y; Yamaguchi E; Sasaki A; Shoji M; Ohnishi Y; Okamoto H; Uehara Y
Chem Biol; 2014 Apr; 21(4):530-540. PubMed ID: 24684907
[TBL] [Abstract][Full Text] [Related]
15. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
16. A protein kinase A (PKA)/β-catenin pathway sustains the BMP2/DLX3-induced osteogenic differentiation in dental follicle cells (DFCs).
Viale-Bouroncle S; Klingelhöffer C; Ettl T; Reichert TE; Morsczeck C
Cell Signal; 2015 Mar; 27(3):598-605. PubMed ID: 25530217
[TBL] [Abstract][Full Text] [Related]
17. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
Zhou AD; Diao LT; Xu H; Xiao ZD; Li JH; Zhou H; Qu LH
Oncogene; 2012 Jun; 31(24):2968-78. PubMed ID: 22020335
[TBL] [Abstract][Full Text] [Related]
18. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
20. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
